Labcorp LH shares have rallied 25.6% in the past year, reflecting sustained momentum and outperforming the industry’s 16.2% fall and the S&P 500 composite’s 9.1% gain. Carrying a Zacks Rank #3 (Hold) ...

Burlington, North Carolina-based Labcorp Holdings Inc. (LH) is a provider of laboratory services. It offers various tests, such as blood chemistry analyses, urinalyses, thyroid, PAP, substance abuse, ...

Labcorp Holdings Inc. LH, or Labcorp’s strong focus on key areas such as oncology, women’s health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17. Sales increased 9.5% year-over-year ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Labcorp Holdings has rallied 27% on multiple expansion, but growth prospects remain moderate and capital intensity is rising. Q2 results showed solid revenue and margin gains, with raised guidance, ...

Laboratory Corporation of America Holdings (NYSE:LH) is one of the best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock’s ‘Overweight’ rating and raised the 12-month ...

Principal Financial Group Inc. grew its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 0.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 95,004 ...